Anupam Rasayan India (ANURAS) Stock Overview
Engages in the custom synthesis and manufacturing of specialty chemicals in India, Europe, Japan, Singapore, China, North America, and internationally. More details
| Snowflake Score | |
|---|---|
| Valuation | 0/6 |
| Future Growth | 4/6 |
| Past Performance | 5/6 |
| Financial Health | 3/6 |
| Dividends | 0/6 |
Rewards
Risk Analysis
No risks detected for ANURAS from our risk checks.
ANURAS Community Fair Values
Create NarrativeSee what others think this stock is worth. Follow their fair value or set your own to get alerts.
Analyst Price Targets
Anupam Rasayan India Ltd Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | ₹1,270.70 |
| 52 Week High | ₹1,415.00 |
| 52 Week Low | ₹1,045.20 |
| Beta | 0.11 |
| 1 Month Change | -6.98% |
| 3 Month Change | 0.29% |
| 1 Year Change | 10.78% |
| 3 Year Change | 22.28% |
| 5 Year Change | 68.38% |
| Change since IPO | 141.21% |
Recent News & Updates
Narrative Update • Jun 08
ANURAS: Upcoming Debt Raise And Subsidiary Guarantees Will Support Future Upside
Analysts have inched up their fair value estimate for Anupam Rasayan India from ₹1,667.80 to ₹1,680.00, citing updated assumptions around discount rate, revenue growth, profit margins and future P/E multiples. What's in the News The board has scheduled a meeting on May 23, 2026, to consider and approve audited standalone and consolidated financial results for the quarter and year ended March 31, 2026, and to recommend a final dividend for FY 2025-26.
Narrative Update • May 25
ANURAS: Planned Debt Issuance Will Sustain An Unfavorable Risk Profile
Analysts have lifted their price target on Anupam Rasayan India from ₹625 to ₹640, citing updated assumptions around discount rate, revenue growth, profit margin and future P/E as the key drivers of this change. What's in the News A board meeting is scheduled for May 23, 2026 at 12:45 IST to review and approve the audited standalone and consolidated financial results for the quarter and year ended March 31, 2026, and to consider a final dividend on equity shares for FY 2025-26 (company filing).Recent updates
Narrative Update • Jun 08
ANURAS: Upcoming Debt Raise And Subsidiary Guarantees Will Support Future Upside
Analysts have inched up their fair value estimate for Anupam Rasayan India from ₹1,667.80 to ₹1,680.00, citing updated assumptions around discount rate, revenue growth, profit margins and future P/E multiples. What's in the News The board has scheduled a meeting on May 23, 2026, to consider and approve audited standalone and consolidated financial results for the quarter and year ended March 31, 2026, and to recommend a final dividend for FY 2025-26.Narrative Update • May 25
ANURAS: Planned Debt Issuance Will Sustain An Unfavorable Risk Profile
Analysts have lifted their price target on Anupam Rasayan India from ₹625 to ₹640, citing updated assumptions around discount rate, revenue growth, profit margin and future P/E as the key drivers of this change. What's in the News A board meeting is scheduled for May 23, 2026 at 12:45 IST to review and approve the audited standalone and consolidated financial results for the quarter and year ended March 31, 2026, and to consider a final dividend on equity shares for FY 2025-26 (company filing).Narrative Update • May 06
ANURAS: Upcoming Overseas Subsidiary Guarantees Will Support Future Upside
Analysts have slightly adjusted their price target for Anupam Rasayan India to around ₹1,668, reflecting updated assumptions on the discount rate, revenue growth, profit margin and future P/E multiples. What's in the News A special shareholders meeting is scheduled for May 7, 2026 via postal ballot to seek approval for guarantees and security interests linked to the credit facility of wholly owned subsidiary Doriath S.à.r.l. This may include security over the shares and assets of Doriath S.à.r.l and Jayhawk Fine Chemicals Corporation (company filing).Narrative Update • Apr 21
ANURAS: Upcoming Board Actions On Overseas Units Will Support Future Upside
Analysts have kept their fair value estimate for Anupam Rasayan India broadly unchanged at about ₹1,668, citing slight tweaks to the discount rate, revenue growth, profit margin and future P/E inputs that together support this stable price target view. What's in the News A board meeting is scheduled on Feb 12, 2026, to consider 12,000 shares of Doriath S.à r.l.; 1,800 shares of Batam S.à r.l. representing a 15% equity stake; potential credit facility transactions; an ECB facility agreement with Axis Bank Limited, IBU GIFT City; appointment of Axis Trustee Services Limited as security trustee; and other matters (Key Developments).Narrative Update • Apr 07
ANURAS: Overseas Subsidiary Financing Structure Will Support Future Upside Potential
Analysts have nudged their fair value estimate for Anupam Rasayan India to about ₹1,668. This change is linked to updated assumptions on discount rate, revenue growth, profit margin and future P/E.
Narrative Update • Mar 23
ANURAS: Upcoming Credit Facilities And Subsidiary Transactions Will Pressure Sentiment Through 2026
The analyst price target for Anupam Rasayan India has been revised from ₹922 to ₹976, with analysts citing updated assumptions on the discount rate, revenue growth, profit margins and future P/E multiples to support the new view. What's in the News Board meeting on Feb 12, 2026 to review 12,000 shares of Doriath S.à r.l., a wholly owned subsidiary, and 1,800 shares of Batam S.à r.l. representing a 15% equity stake in Batam (Key Developments).Narrative Update • Mar 09
ANURAS: Overseas Acquisitions And Expanded Borrowing Capacity Will Drive Future Upside
Analysts have nudged their fair value estimate for Anupam Rasayan India to about ₹1,668 per share, reflecting slightly adjusted assumptions around discount rate, revenue growth, profit margin and future P/E that leave the overall valuation picture broadly unchanged. What's in the News A board meeting is scheduled for Feb 12, 2026 to review the potential acquisition of 12,000 shares of Doriath S.à r.l. and 1,800 shares of Batam S.à r.l. representing 15% equity in Batam, and to consider new credit facilities and related security arrangements with Axis Bank Limited and Axis Trustee Services Limited (Key Developments).Narrative Update • Feb 23
ANURAS: Future Overseas Acquisitions And Borrowing Headroom Will Redefine Upside Potential
Analysts have lifted their fair value estimate for Anupam Rasayan India from ₹1,305.00 to about ₹1,667.80, reflecting updated assumptions around discount rate, revenue growth, profit margin and future P/E expectations. What's in the News Board meeting on Feb 12, 2026 to review acquisition of 12,000 shares of Doriath S.à r.l., a wholly owned subsidiary, and 1,800 shares in Batam S.à r.l. representing a 15% equity stake, along with related credit facility arrangements, including an ESCB Facility with Axis Bank Limited, IBU GIFT City, and appointment of Axis Trustee Services Limited as security trustee under an ECB Facility (company board notice).Narrative Update • Feb 08
ANURAS: Planned Acquisition And Higher Leverage Will Sustain An Unfavorable Risk Profile
Analysts have kept their fair value estimate for Anupam Rasayan India steady at ₹625.00 per share, highlighting slightly adjusted assumptions around discount rate, revenue growth and profit margin as the key drivers behind the unchanged target. What's in the News A board meeting is scheduled for Feb 14, 2026 to consider and approve unaudited financial results for the quarter and nine months ended Dec 31, 2025, providing the next formal update on recent financial performance (company filing).Narrative Update • Jan 25
ANURAS: Planned Acquisition And Higher Leverage Will Drive An Unfavorable Risk Profile
Analysts have raised their price target on Anupam Rasayan India from ₹520 to ₹625, citing updated assumptions for profit margins, growth and P/E that they consider better reflect the stock’s risk profile and return outlook. What's in the News Board meeting on Dec 09, 2025 to consider and approve the acquisition of Monitchem Kansas S.à r.l and its subsidiaries, along with a related loan receivable from CABB GmbH, and the execution of a Sale and Purchase Agreement (company filing).Analysis Article • Jan 21
Investors Met With Slowing Returns on Capital At Anupam Rasayan India (NSE:ANURAS)
If we want to find a potential multi-bagger, often there are underlying trends that can provide clues. Firstly, we'll...Narrative Update • Jan 08
ANURAS: Planned Acquisition And Higher Leverage Will Pressure Sentiment Through 2026
Analysts have lifted their fair value estimate for Anupam Rasayan India from ₹905 to about ₹922, citing updated assumptions for the discount rate, long term revenue growth, profit margins and the future P/E multiple. What's in the News The board will meet on Dec 09, 2025 to consider and approve the acquisition of Monitchem Kansas S.à r.l and its subsidiaries, along with a related loan receivable from CABB GmbH, and to authorize a Sale and Purchase Agreement and postal ballot notice.Analysis Article • Dec 16
Is Anupam Rasayan India (NSE:ANURAS) A Risky Investment?
Legendary fund manager Li Lu (who Charlie Munger backed) once said, 'The biggest investment risk is not the volatility...Narrative Update • Dec 14
ANURAS: Acquisition And Auditor Shift Will Pressure Sentiment Through 2026
Analysts have nudged their price target for Anupam Rasayan India slightly higher to ₹905.0 from ₹905, citing marginal improvements in the discount rate and long term profitability assumptions while keeping growth expectations largely intact. What's in the News Board meeting scheduled for December 09, 2025 to consider the acquisition of Monitchem Kansas S.à r.l and its subsidiaries, along with related loan receivable and Sale and Purchase Agreement approvals (company filing) Special shareholders meeting via postal ballot on January 09, 2026 to seek investor approval for the proposed acquisition and related resolutions (company filing) Special shareholders meeting via postal ballot on December 22, 2025, with voting conducted through remote e-voting (company filing) Board meeting held on November 21, 2025 to approve the postal ballot notice, set the cut-off date, define the e-voting window, and appoint a scrutinizer for the postal ballot process (company filing) Board meeting on October 17, 2025 to review and approve unaudited standalone and consolidated financial results for the quarter and half year ended September 30, 2025 (company filing) Shareholders at the September 26, 2025 AGM approved the appointment of Natvarlal Vepari and Co., Chartered Accountants, Surat, as the company’s new statutory auditor (company filing) Valuation Changes Fair Value: Maintained effectively flat at ₹905.0, reflecting no material change in the intrinsic value estimate.Narrative Update • Nov 30
ANURAS: Auditor Transition And Board Actions Will Pressure Sentiment Through 2025
Analysts have maintained their fair value estimate for Anupam Rasayan India at ₹905.00, citing stable forecast assumptions, even with minor adjustments in financial metrics. What's in the News The company scheduled a Special/Extraordinary Shareholders Meeting on December 22, 2025, to be conducted via postal ballot in India.Analysis Article • Nov 20
Anupam Rasayan India Ltd (NSE:ANURAS) Investors Are Less Pessimistic Than Expected
When you see that almost half of the companies in the Chemicals industry in India have price-to-sales ratios (or "P/S...Narrative Update • Nov 16
ANURAS: Net Profit Margin Will Weaken Amid Management And Auditor Changes
Analysts have slightly reduced their price target for Anupam Rasayan India to ₹905.00 per share, citing modest adjustments in profit margin expectations and valuation assumptions. What's in the News A board meeting is scheduled for October 17, 2025 to consider and approve the unaudited financial results for the quarter and half year ended September 30, 2025 (Company Filing).Narrative Update • Nov 01
ANURAS: Slowing Revenue Expansion Will Pressure Margins Despite Profit Recovery
Analysts have raised their price target for Anupam Rasayan India from ₹884.29 to ₹909.29, citing improved profit margin expectations even though projected revenue growth is expected to moderate. What's in the News The board meeting is scheduled for October 17, 2025, to consider and approve unaudited financial results for the quarter and half year ended September 30, 2025 (Key Developments).Narrative Update • Oct 18
Growing Contract Wins And Tightening Margins Will Shape Future Prospects
Analysts have revised their price target for Anupam Rasayan India upward from ₹838 to ₹884. They cited slight adjustments in the discount rate and an upward recalibration of fair value in their latest models.Analysis Article • Oct 02
Returns On Capital At Anupam Rasayan India (NSE:ANURAS) Have Hit The Brakes
If we want to find a stock that could multiply over the long term, what are the underlying trends we should look for...Narrative Update • Aug 22
Expanding Pharma And Polymer Segments To Drive Future Success
Despite a notable reduction in consensus revenue growth forecasts, expectations for Anupam Rasayan India's earnings multiple have increased, resulting in a higher analyst price target now at ₹837.86. What's in the News Board meeting scheduled to consider and approve unaudited Q1 FY26 financial results.Analysis Article • May 28
Anupam Rasayan India Ltd Just Missed EPS By 7.1%: Here's What Analysts Think Will Happen Next
Investors in Anupam Rasayan India Ltd ( NSE:ANURAS ) had a good week, as its shares rose 3.0% to close at ₹991...Analysis Article • Apr 08
Anupam Rasayan India Ltd (NSE:ANURAS) Not Lagging Industry On Growth Or Pricing
When you see that almost half of the companies in the Chemicals industry in India have price-to-sales ratios (or "P/S...
New Narrative • Mar 11
Expanding Pharma And Polymer Segments To Drive Future Success
Pharma and Polymer growth, energy cost cuts, and a robust pipeline with new molecules will drive future revenue growth and improve net margins.Analysis Article • Nov 25
Anupam Rasayan India's (NSE:ANURAS) Problems Go Beyond Weak Profit
A lackluster earnings announcement from Anupam Rasayan India Ltd ( NSE:ANURAS ) last week didn't sink the stock price...Analysis Article • Nov 18
Earnings Report: Anupam Rasayan India Ltd Missed Revenue Estimates By 9.2%
The second-quarter results for Anupam Rasayan India Ltd ( NSE:ANURAS ) were released last week, making it a good time...Analysis Article • Nov 02
Anupam Rasayan India (NSE:ANURAS) Hasn't Managed To Accelerate Its Returns
There are a few key trends to look for if we want to identify the next multi-bagger. One common approach is to try and...Analysis Article • Aug 24
Time To Worry? Analysts Just Downgraded Their Anupam Rasayan India Ltd (NSE:ANURAS) Outlook
Today is shaping up negative for Anupam Rasayan India Ltd ( NSE:ANURAS ) shareholders, with the analysts delivering a...Analysis Article • Aug 17
Anupam Rasayan India Ltd Earnings Missed Analyst Estimates: Here's What Analysts Are Forecasting Now
As you might know, Anupam Rasayan India Ltd ( NSE:ANURAS ) last week released its latest quarterly, and things did not...Analysis Article • May 26
Anupam Rasayan India's (NSE:ANURAS) Shareholders Have More To Worry About Than Only Soft Earnings
A lackluster earnings announcement from Anupam Rasayan India Limited ( NSE:ANURAS ) last week didn't sink the stock...Analysis Article • May 22
Analyst Estimates: Here's What Brokers Think Of Anupam Rasayan India Limited (NSE:ANURAS) After Its Full-Year Report
Last week saw the newest annual earnings release from Anupam Rasayan India Limited ( NSE:ANURAS ), an important...Analysis Article • Dec 30
What You Can Learn From Anupam Rasayan India Ltd's (NSE:ANURAS) P/E
When close to half the companies in India have price-to-earnings ratios (or "P/E's") below 29x, you may consider Anupam...Analysis Article • Nov 03
Anupam Rasayan India (NSE:ANURAS) Might Have The Makings Of A Multi-Bagger
Did you know there are some financial metrics that can provide clues of a potential multi-bagger? Amongst other things...Analysis Article • Jul 13
Is Now The Time To Put Anupam Rasayan India (NSE:ANURAS) On Your Watchlist?
Investors are often guided by the idea of discovering 'the next big thing', even if that means buying 'story stocks...Analysis Article • Jun 24
Anupam Rasayan India's (NSE:ANURAS) Returns On Capital Are Heading Higher
To find a multi-bagger stock, what are the underlying trends we should look for in a business? Amongst other things...Shareholder Returns
| ANURAS | IN Chemicals | IN Market | |
|---|---|---|---|
| 7D | 0.7% | 1.8% | 2.1% |
| 1Y | 10.8% | -0.8% | 1.5% |
Return vs Industry: ANURAS exceeded the Indian Chemicals industry which returned -0.8% over the past year.
Return vs Market: ANURAS exceeded the Indian Market which returned 1.5% over the past year.
Price Volatility
| ANURAS volatility | |
|---|---|
| ANURAS Average Weekly Movement | 3.4% |
| Chemicals Industry Average Movement | 7.2% |
| Market Average Movement | 7.1% |
| 10% most volatile stocks in IN Market | 10.2% |
| 10% least volatile stocks in IN Market | 4.6% |
Stable Share Price: ANURAS has not had significant price volatility in the past 3 months compared to the Indian market.
Volatility Over Time: ANURAS's weekly volatility (3%) has been stable over the past year.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 1984 | 2,606 | Gopal Agrawal | www.anupamrasayan.com |
Anupam Rasayan India Ltd engages in the custom synthesis and manufacturing of specialty chemicals in India, Europe, Japan, Singapore, China, North America, and internationally. It operates through two segments: Life Science related Specialty Chemicals and Other Specialty Chemicals. The company offers life science related specialty chemicals, such as agro intermediates and agro active ingredients for the agrochemicals industry; anti-bacterial and ultraviolet protection intermediates and ingredients for the personal care industry; and intermediates and key starting materials for active pharmaceutical ingredients.
Anupam Rasayan India Ltd Fundamentals Summary
| ANURAS fundamental statistics | |
|---|---|
| Market cap | ₹145.99b |
| Earnings (TTM) | ₹1.70b |
| Revenue (TTM) | ₹23.65b |
85.0x
P/E Ratio6.1x
P/S RatioIs ANURAS overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| ANURAS income statement (TTM) | |
|---|---|
| Revenue | ₹23.65b |
| Cost of Revenue | ₹13.23b |
| Gross Profit | ₹10.42b |
| Other Expenses | ₹8.72b |
| Earnings | ₹1.70b |
Last Reported Earnings
Mar 31, 2026
Next Earnings Date
n/a
| Earnings per share (EPS) | 14.94 |
| Gross Margin | 44.06% |
| Net Profit Margin | 7.19% |
| Debt/Equity Ratio | 39.2% |
How did ANURAS perform over the long term?
See historical performance and comparisonDividends
0.1%
Current Dividend Yield10%
Payout RatioCompany Analysis and Financial Data Status
| Data | Last Updated (UTC time) |
|---|---|
| Company Analysis | 2026/06/23 14:20 |
| End of Day Share Price | 2026/06/23 00:00 |
| Earnings | 2026/03/31 |
| Annual Earnings | 2026/03/31 |
Data Sources
The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.
| Package | Data | Timeframe | Example US Source * |
|---|---|---|---|
| Company Financials | 10 years |
| |
| Analyst Consensus Estimates | +3 years |
|
|
| Market Prices | 30 years |
| |
| Ownership | 10 years |
| |
| Management | 10 years |
| |
| Key Developments | 10 years |
|
* Example for US securities, for non-US equivalent regulatory forms and sources are used.
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more.
Analysis Model and Snowflake
Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.
Learn about the world class team who designed and built the Simply Wall St analysis model.
Industry and Sector Metrics
Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on Github.
Analyst Sources
Anupam Rasayan India Ltd is covered by 10 analysts. 4 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.
| Analyst | Institution |
|---|---|
| Ankur Periwal | Axis Capital Limited |
| Satish Kumar | CGS International |
| Dane Leone | CGS International |